Key Points
-
The low-density lipoprotein (LDL) receptor gene family forms a class of multifunctional lipoprotein receptors that mediate the cellular uptake of cholesterol and other lipids. They also transmit, modulate and integrate a broad range of extracellular signals that include, for example, the control of cellular proliferation, migration, development and neurotransmission.
-
Reelin, a large extracellular signalling molecule, controls neuronal migration and positioning during brain development by binding to the apolipoprotein E (APOE) receptors very low-density lipoprotein receptor (VLDLR) and APOE receptor 2 (APOER2).
-
In the adult brain, reelin signalling assumes a new role in the control of synaptic plasticity by regulating the activity of NMDA (N-methyl-D-aspartate) receptors. This also involves differential splicing of one of the reelin receptors, APOER2.
-
Reelin signalling through APOE receptors also stabilizes microtubules and prevents tau (τ) hyperphosphorylation and thereby possibly the formation of neurofibrillary tangles, a histopathological hallmark of Alzheimer's disease.
-
Genetic defects in the reelin pathway disrupt normal brain development and cause mental retardation in humans.
-
Cholesterol is a key component of cellular membranes and as such has a crucial role in synaptic functions, as well as in the processing of the amyloid-β (Aβ) protein. This short peptide is not only the main component of the plaques in the brains of patients with Alzheimer's disease but also a modulator of synaptic plasticity.
-
APOE, a cholesterol-carrying ligand for the lipoprotein receptors of the LDL receptor gene family, is genetically associated with late-onset Alzheimer's disease. The emerging functions of Aβ, cholesterol and APOE receptors in neurons and particularly in synapses point towards a probable role for these signal-transducing lipoprotein receptors in the disease process.
Abstract
Apolipoprotein E (APOE) is a cholesterol transport protein and an isoform-specific major risk factor for neurodegenerative diseases. The lipoprotein receptors that bind APOE have recently been recognized as pivotal components of the neuronal signalling machinery. The interaction between APOE receptors and one of their ligands, reelin, allows them to function directly as signal transduction receptors at the plasma membrane to control not only neuronal positioning during brain development, but also synaptic plasticity in the adult brain. Here, we review the molecular mechanisms through which APOE, cholesterol, reelin and APOE receptors control synaptic functions that are essential for cognition, learning, memory, behaviour and neuronal survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schmechel, D. E. et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 9649–9653 (1993).
Strittmatter, W. J. et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 1977–1981 (1993). References 1 and 2 are the seminal papers that revealed the isoform-selective role of APOE in the development of late-onset AD.
D'Arcangelo, G. et al. Reelin is a ligand for lipoprotein receptors. Neuron 24, 471–479 (1999).
Hiesberger, T. et al. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates τ phosphorylation. Neuron 24, 481–489 (1999).
Trommsdorff, M. et al. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689–701 (1999).
Simons, M. et al. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc. Natl Acad. Sci. USA 95, 6460–6464 (1998). The first report on the role of membrane cholesterol homeostasis in the regulation of Aβ peptide generation.
Mauch, D. H. et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354–1357 (2001). Reveals the role of cholesterol production and transport from glia to neurons for the generation of new synapses.
D'Arcangelo, G. et al. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374, 719–723 (1995).
Falconer, D. S. Two new mutants 'trembler' and 'reeler' with neurological actions in the house mouse. J. Genet. 50, 192–201 (1951).
Takahara, T. et al. Dysfunction of the Orleans reeler gene arising from exon skipping due to transposition of a full-length copy of an active L1 sequence into the skipped exon. Hum. Mol. Genet. 5, 989–993 (1996).
Bar, I. & Goffinet, A. M. Evolution of cortical lamination: the reelin/Dab1 pathway. Novartis Found. Symp. 228, 114–125; discussion 125–128 (2000).
Rice, D. S. & Curran, T. Role of the reelin signaling pathway in central nervous system development. Annu. Rev. Neurosci. 24, 1005–1039 (2001).
Tissir, F. & Goffinet, A. M. Reelin and brain development. Nature Rev. Neurosci. 4, 496–505 (2003). A superb review of the importance of the reelin signalling pathway during brain development.
Forster, E., Zhao, S. & Frotscher, M. Laminating the hippocampus. Nature Rev. Neurosci. 7, 259–267 (2006).
Caviness, V. S. Jr. Neocortical histogenesis in normal and reeler mice: a developmental study based upon [3H]thymidine autoradiography. Brain Res. 256, 293–302 (1982).
Caviness, V. S. Jr. & Sidman, R. L. Time of origin or corresponding cell classes in the cerebral cortex of normal and reeler mutant mice: an autoradiographic analysis. J. Comp. Neurol. 148, 141–151 (1973).
Mariani, J., Crepel, F., Mikoshiba, K., Changeux, J. P. & Sotelo, C. Anatomical, physiological and biochemical studies of the cerebellum from Reeler mutant mouse. Philos. Trans. R. Soc. Lond. B Biol. Sci. 281, 1–28 (1977).
Wallace, V. A. Purkinje-cell-derived Sonic hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum. Curr. Biol. 9, 445–448 (1999).
Howell, B. W., Hawkes, R., Soriano, P. & Cooper, J. A. Neuronal position in the developing brain is regulated by mouse disabled-1. Nature 389, 733–737 (1997).
Sheldon, M. et al. Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice. Nature 389, 730–733 (1997).
Sweet, H. O., Bronson, R. T., Johnson, K. R., Cook, S. A. & Davisson, M. T. Scrambler, a new neurological mutation of the mouse with abnormalities of neuronal migration. Mamm. Genome 7, 798–802 (1996).
Gotthardt, M. et al. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J. Biol. Chem. 275, 25616–25624 (2000).
Hirotsune, S. et al. The reeler gene encodes a protein with an EGF-like motif expressed by pioneer neurons. Nature Genet. 10, 77–83 (1995). Together with references 5, 10, 19, 20 and 21, this paper establishes the sequence of reelin, VLDLR and APOER2, and DAB1 in a linear pathway at the neuronal plasma membrane.
Howell, B. W., Herrick, T. M. & Cooper, J. A. Reelin-induced tryosine phosphorylation of disabled 1 during neuronal positioning. Genes Dev. 13, 643–648 (1999).
Stolt, P. C. et al. Origins of peptide selectivity and phosphoinositide binding revealed by structures of disabled-1 PTB domain complexes. Structure 11, 569–579 (2003).
Trommsdorff, M., Borg, J. P., Margolis, B. & Herz, J. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273, 33556–33560 (1998).
Yun, M. et al. Crystal structures of the Dab homology domains of mouse disabled 1 and 2. J. Biol. Chem. 278, 36572–36581 (2003).
Strasser, V. et al. Receptor clustering is involved in Reelin signaling. Mol. Cell Biol. 24, 1378–1386 (2004).
Riddell, D. R., Sun, X. M., Stannard, A. K., Soutar, A. K. & Owen, J. S. Localization of apolipoprotein E receptor 2 to caveolae in the plasma membrane. J. Lipid Res. 42, 998–1002 (2001).
Mayer, H., Duit, S., Hauser, C., Schneider, W. J. & Nimpf, J. Reconstitution of the Reelin signaling pathway in fibroblasts demonstrates that Dab1 phosphorylation is independent of receptor localization in lipid rafts. Mol. Cell Biol. 26, 19–27 (2006).
Utsunomiya-Tate, N. et al. Reelin molecules assemble together to form a large protein complex, which is inhibited by the function-blocking CR-50 antibody. Proc. Natl Acad. Sci. USA 97, 9729–9734 (2000).
Bock, H. H. & Herz, J. Reelin activates SRC family tyrosine kinases in neurons. Curr. Biol. 13, 18–26 (2003).
Arnaud, L., Ballif, B. A., Forster, E. & Cooper, J. A. Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development. Curr. Biol. 13, 9–17 (2003).
Beffert, U. et al. Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3β. J. Biol. Chem. 277, 49958–49964 (2002).
Assadi, A. H. et al. Interaction of reelin signaling and Lis1 in brain development. Nature Genet. 35, 270–276 (2003).
Arnaud, L., Ballif, B. A. & Cooper, J. A. Regulation of protein tyrosine kinase signaling by substrate degradation during brain development. Mol. Cell Biol. 23, 9293–9302 (2003).
Morimura, T., Hattori, M., Ogawa, M. & Mikoshiba, K. Disabled1 regulates the intracellular trafficking of reelin receptors. J. Biol. Chem. 280, 16901–16908 (2005).
Bock, H. H., Jossin, Y., May, P., Bergner, O. & Herz, J. Apolipoprotein E receptors are required for reelin-induced proteasomal degradation of the neuronal adaptor protein Disabled-1. J. Biol. Chem. 279, 33471–33479 (2004).
Herz, J. & Bock, H. H. Lipoprotein receptors in the nervous system. Annu. Rev. Biochem. 71, 405–434 (2002).
Herz, J. & Beffert, U. Apolipoprotein E receptors: linking brain development and Alzheimer's disease. Nature Rev. Neurosci. 1, 51–58 (2000).
Ohkubo, N. et al. Apolipoprotein E and Reelin ligands modulate τ phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3β cascade. FASEB J. 17, 295–297 (2003).
Brich, J. et al. Genetic modulation of τ phosphorylation in the mouse. J. Neurosci. 23, 187–192 (2003).
Homayouni, R., Rice, D. S., Sheldon, M. & Curran, T. Disabled-1 binds to the cytoplasmic domain of amyloid precursor-like protein 1. J. Neurosci. 19, 7507–7515 (1999).
Howell, B. W., Lanier, L. M., Frank, R., Gertler, F. B. & Cooper, J. A. The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids. Mol. Cell Biol. 19, 5179–5188 (1999).
Hoe, H. S., Tran, T. S., Matsuoka, Y., Howell, B. W. & Rebeck, G. W. Dab1 and Reelin effects on APP and ApoEr2 trafficking and processing. J. Biol. Chem. 1 Sept 2006 (doi: 10.1074/jbc.M602162200).
Bacskai, B. J., Xia, M. Q., Strickland, D. K., Rebeck, G. W. & Hyman, B. T. The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors. Proc. Natl Acad. Sci. USA 97, 11551–11556 (2000).
Qiu, Z., Crutcher, K. A., Hyman, B. T. & Rebeck, G. W. ApoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience 122, 291–303 (2003).
Qiu, Z., Strickland, D. K., Hyman, B. T. & Rebeck, G. W. α 2-Macroglobulin exposure reduces calcium responses to N-methyl-D-aspartate via low density lipoprotein receptor-related protein in cultured hippocampal neurons. J. Biol. Chem. 277, 14458–14466 (2002).
May, P. et al. Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol. Cell. Biol. 24, 8872–8883 (2004).
Simons, K. & Toomre, D. Lipid rafts and signal transduction. Nature Rev. Mol. Cell. Biol. 1, 31–39 (2000).
Fassbender, K. et al. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ 42 and Aβ 40 in vitro and in vivo. Proc. Natl Acad. Sci. USA 98, 5856–5861 (2001).
Kamenetz, F. et al. APP processing and synaptic function. Neuron 37, 925–937 (2003).
Boyles, J. K. et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest. 83, 1015–1031 (1989).
Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W. & Taylor, J. M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76, 1501–1513 (1985).
Pitas, R. E., Boyles, J. K., Lee, S. H., Hui, D. & Weisgraber, K. H. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain. J. Biol. Chem. 262, 14352–14360 (1987).
Pfrieger, F. W. & Barres, B. A. Synaptic efficacy enhanced by glial cells in vitro. Science 277, 1684–1687 (1997).
Masliah, E. et al. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136, 107–122 (1995).
Buttini, M. et al. Expression of human apolipoprotein E3 or E4 in the brains of Apoe−/− mice: isoform-specific effects on neurodegeneration. J. Neurosci. 19, 4867–4880 (1999).
Raber, J. et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc. Natl Acad. Sci. USA 95, 10914–10919 (1998).
Kotti, T. J., Ramirez, D. M., Pfeiffer, B. E., Huber, K. M. & Russell, D. W. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc. Natl Acad. Sci. USA 103, 3869–3874 (2006). An original study that reveals the role of de novo cholesterol biosynthesis, pathway intermediates and turnover for synaptic neurotransmission in mouse brains.
Lund, E. G. et al. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278, 22980–22988 (2003).
Gordon, I., Grauer, E., Genis, I., Sehayek, E. & Michaelson, D. M. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199, 1–4 (1995).
Valastro, B., Ghribi, O., Poirier, J., Krzywkowski, P. & Massicotte, G. AMPA receptor regulation and LTP in the hippocampus of young and aged apolipoprotein E-deficient mice. Neurobiol. Aging 22, 9–15 (2001).
Kelly, A. & Lynch, M. A. LTP occludes the interaction between arachidonic acid and ACPD and NGF and ACPD. Neuroreport 9, 4087–4091 (1998).
Anderson, R. et al. Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse. Neuroscience 85, 93–110 (1998).
Trommer, B. L. et al. ApoE isoform affects LTP in human targeted replacement mice. Neuroreport 15, 2655–2658 (2004).
Kitamura, H. W. et al. Age-dependent enhancement of hippocampal long-term potentiation in knock-in mice expressing human apolipoprotein E4 instead of mouse apolipoprotein E. Neurosci. Lett. 369, 173–178 (2004).
Nathan, B. P. et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850–852 (1994).
Chang, S. et al. Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc. Natl Acad. Sci. USA 102, 18694–18699 (2005).
Huang, Y. et al. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc. Natl Acad. Sci. USA 98, 8838–8843 (2001).
Mahley, R. W., Weisgraber, K. H. & Huang, Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl Acad. Sci. USA 103, 5644–5651 (2006). An excellent review of potential mechanisms through which APOE*ε4 might cause neuropathology and AD.
Allen, J. S., Bruss, J. & Damasio, H. The aging brain: the cognitive reserve hypothesis and hominid evolution. Am. J. Hum. Biol. 17, 673–689 (2005).
Zhuo, M. et al. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J. Neurosci. 20, 542–549 (2000).
Moestrup, S. K., Gliemann, J. & Pallesen, G. Distribution of the α 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res. 269, 375–382 (1992).
Melchor, J. P. & Strickland, S. Tissue plasminogen activator in central nervous system physiology and pathology. Thromb. Haemost. 93, 655–660 (2005).
Pawlak, R., Magarinos, A. M., Melchor, J., McEwen, B. & Strickland, S. Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nature Neurosci. 6, 168–174 (2003).
Tsirka, S. E., Rogove, A. D., Bugge, T. H., Degen, J. L. & Strickland, S. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J. Neurosci. 17, 543–552 (1997).
Harris-White, M. E. & Frautschy, S. A. Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition. Curr. Drug Targets CNS Neurol. Disord. 4, 469–480 (2005).
Pang, P. T. & Lu, B. Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF. Ageing Res. Rev. 3, 407–430 (2004).
Baranes, D. et al. Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21, 813–825 (1998).
Lavdas, A. A., Grigoriou, M., Pachnis, V. & Parnavelas, J. G. The medial ganglionic eminence gives rise to a population of early neurons in the developing cerebral cortex. J. Neurosci. 19, 7881–7888 (1999).
Weeber, E. J. et al. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem. 277, 39944–39952 (2002).
Beffert, U. et al. Functional dissection of Reelin signaling by site-directed disruption of Disabled-1 adaptor binding to apolipoprotein E receptor 2: distinct roles in development and synaptic plasticity. J. Neurosci. 26, 2041–2052 (2006). References 82 and 83 are the original articles that first reported on the role of reelin as an enhancer of LTP, memory and learning, and on the regulation in vivo of the cytoplasmic domain of APOER2 through regulated splicing.
Beffert, U. et al. Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron 47, 567–579 (2005).
Stockinger, W. et al. The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and-2. J. Biol. Chem. 275, 25625–25632 (2000).
Chen, Y. et al. Reelin modulates NMDA receptor activity in cortical neurons. J. Neurosci. 25, 8209–8216 (2005).
Hoe, H. S. et al. Apolipoprotein E receptor 2 interactions with the N-methyl-D-aspartate receptor. J. Biol. Chem. 281, 3425–3431 (2006).
Brandes, C. et al. Alternative splicing in the ligand binding domain of mouse ApoE receptor-2 produces receptor variants binding reelin but not α 2-macroglobulin. J. Biol. Chem. 276, 22160–22169 (2001).
Qiu, S. et al. Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice. Neurobiol. Learn. Mem. 85, 228–242 (2006). A detailed electrophysiological study on the heterozygous reeler mouse reveals profound defects in cognition, hippocampal functions and the regulation of GABA-mediated inhibitory circuitry.
Sinagra, M. et al. Reelin, very-low-density lipoprotein receptor, and apolipoprotein E receptor 2 control somatic NMDA receptor composition during hippocampal maturation in vitro. J. Neurosci. 25, 6127–6136 (2005).
Niu, S., Renfro, A., Quattrocchi, C. C., Sheldon, M. & D'Arcangelo, G. Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway. Neuron 41, 71–84 (2004).
Borrell, V. et al. Reelin regulates the development and synaptogenesis of the layer-specific entorhino-hippocampal connections. J. Neurosci. 19, 1345–1358 (1999).
Del Rio, J. A. et al. A role for Cajal–Retzius cells and reelin in the development of hippocampal connections. Nature 385, 70–74 (1997).
Guidotti, A. et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 57, 1061–1069 (2000).
Impagnatiello, F. et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl Acad. Sci. USA 95, 15718–15723 (1998).
Fatemi, S. H., Kroll, J. L. & Stary, J. M. Altered levels of Reelin and its isoforms in schizophrenia and mood disorders. Neuroreport 12, 3209–3215 (2001).
Fatemi, S. H., Earle, J. A. & McMenomy, T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol. Psychiatry 5, 654–663, 571 (2000).
Fatemi, S. H. et al. Reelin signaling is impaired in autism. Biol. Psychiatry 57, 777–787 (2005).
Kamiya, A. et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nature Cell Biol. 7, 1167–1178 (2005).
Coyle, J. T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell. Mol. Neurobiol. 14 Jun 2006 (doi: 10.007.s10571-006-9062-8).
Salinger, W. L., Ladrow, P. & Wheeler, C. Behavioral phenotype of the reeler mutant mouse: effects of RELN gene dosage and social isolation. Behav. Neurosci. 117, 1257–1275 (2003).
Grayson, D. R. et al. Reelin promoter hypermethylation in schizophrenia. Proc. Natl Acad. Sci. USA 102, 9341–9346 (2005).
Heinrich, C. et al. Reelin deficiency and displacement of mature neurons, but not neurogenesis, underlie the formation of granule cell dispersion in the epileptic hippocampus. J. Neurosci. 26, 4701–4713 (2006).
Haas, C. A. et al. Role for reelin in the development of granule cell dispersion in temporal lobe epilepsy. J. Neurosci. 22, 5797–5802 (2002).
Yip, Y. P. et al. Components of the reelin signaling pathway are expressed in the spinal cord. J. Comp. Neurol. 470, 210–219 (2004).
Yip, J. W., Yip, Y. P., Nakajima, K. & Capriotti, C. Reelin controls position of autonomic neurons in the spinal cord. Proc. Natl Acad. Sci. USA 97, 8612–8616 (2000).
Villeda, S. A., Akopians, A. L., Babayan, A. H., Basbaum, A. I. & Phelps, P. E. Absence of Reelin results in altered nociception and aberrant neuronal positioning in the dorsal spinal cord. Neuroscience 139, 1385–1396 (2006).
Hong, S. E. et al. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nature Genet. 26, 93–96 (2000).
Boycott, K. M. et al. Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification. Am. J. Hum. Genet. 77, 477–483 (2005).
Heckenlively, J. R. et al. Mouse model of subretinal neovascularization with choroidal anastomosis. Retina 23, 518–522 (2003).
Bruckner, K. & Klein, R. Signaling by Eph receptors and their ephrin ligands. Curr. Opin. Neurobiol 8, 375–382 (1998). Neuronal activity modulates the formation and secretion of Aβ peptides, which in turn feed back to the synapse and suppress synaptic activity through NMDA receptors.
Zisch, A. H. & Pasquale, E. B. The Eph family: a multitude of receptors that mediate cell recognition signals. Cell Tissue Res. 290, 217–226 (1997).
Grunwald, I. C. et al. Hippocampal plasticity requires postsynaptic ephrinBs. Nature Neurosci. 7, 33–40 (2004).
Grunwald, I. C. et al. Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity. Neuron 32, 1027–1040 (2001).
Henderson, J. T. et al. The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron 32, 1041–1056 (2001).
Dalva, M. B. et al. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell 103, 945–956 (2000).
Takasu, M. A., Dalva, M. B., Zigmond, R. E. & Greenberg, M. E. Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science 295, 491–495 (2002). Together with reference 116, this paper reports that Ephs and ephrins control NMDA receptor functions through mechanisms that resemble those involving reelin and APOE receptors.
Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M. & Selkoe, D. J. Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 572, 477–492 (2006).
Walsh, D. M. et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535–539 (2002).
Snyder, E. M. et al. Regulation of NMDA receptor trafficking by amyloid-β. Nature Neurosci. 8, 1051–1058 (2005).
Bock, H. H. et al. Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J. Biol. Chem. 278, 38772–38779 (2003).
Ballif, B. A. et al. Activation of a Dab1/CrkL/C3G/Rap1 pathway in Reelin-stimulated neurons. Curr. Biol. 14, 606–610 (2004).
Shu, T. et al. Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning. Neuron 44, 263–277 (2004).
Niethammer, M. et al. NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 28, 697–711 (2000).
Smith, D. S. et al. Regulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1. Nature Cell Biol. 2, 767–775 (2000).
Tanaka, T. et al. Lis1 and doublecortin function with dynein to mediate coupling of the nucleus to the centrosome in neuronal migration. J. Cell Biol. 165, 709–721 (2004).
Sasaki, S. et al. A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. Neuron 28, 681–696 (2000).
Ramos-Moreno, T., Galazo, M. J., Porrero, C., Martinez-Cerdeno, V. & Clasca, F. Extracellular matrix molecules and synaptic plasticity: immunomapping of intracellular and secreted Reelin in the adult rat brain. Eur. J. Neurosci. 23, 401–422 (2006).
Lan, J. Y. et al. Protein kinase C modulates NMDA receptor trafficking and gating. Nature Neurosci. 4, 382–390 (2001).
Dunah, A. W. & Standaert, D. G. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J. Neurosci. 21, 5546–5558 (2001).
Heeren, J. et al. Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J. Biol. Chem. 279, 55483–55492 (2004).
Heeren, J. et al. Recycling of apoprotein E is associated with cholesterol efflux and high density lipoprotein internalization. J. Biol. Chem. 278, 14370–14378 (2003).
Ehehalt, R., Keller, P., Haass, C., Thiele, C. & Simons, K. Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts. J. Cell. Biol. 160, 113–123 (2003).
Acknowledgements
The authors acknowledge support by grants from the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Glossary
- Preplate
-
The preplate or primordial plexiform layer (PPL) is a layer composed of afferent and efferent fibres and scattered neurons above the ventricular zone at the embryonic stages of development (Carnegie stages 14–22).
- Cortical plate
-
Outer neural tube region that post-mitotic neuroblasts migrate to along radial glia to form adult cortical layers.
- Lissencephaly
-
Literally meaning 'smooth brain', lissencephaly is a human brain disorder that is characterized by the absence or reduction of the cerebral convolutions.
- Quantitative trait loci
-
(QTLs). Genetic polymorphisms that affect the expression of a continuously distributed phenotype. Typically, QTLs are statistically associated with trait variations that depend on multiple interacting loci.
- Long-term potentiation
-
(LTP). An enduring increase in the amplitude of excitatory postsynaptic potentials as a result of high-frequency stimulation of afferent pathways. It is measured both as the amplitude or differential of excitatory postsynaptic potentials and as the magnitude of the postsynaptic cell population spike. LTP is most frequently studied in the hippocampus and is often considered to be the cellular basis of learning and memory in vertebrates.
- Morris water maze test
-
A task used to assess long-term spatial memory, most commonly in rodents. Animals use an array of extra-maze cues to locate a hidden escape platform that is submerged below the water surface. Learning in this task is hippocampus-dependent.
- Ganglionic eminence
-
The proliferative zone of the ventral telencephalon, which gives rise to the basal ganglia, and also generates some cortical neurons and glia. It consists of lateral, caudal and medial subdivisions.
- Late-phase LTP
-
Transcription- and translation-dependent LTP that is typically induced with multiple, spaced trains of high-frequency stimulation. This type of LTP persists for more than 3 hours.
- Alternative splicing
-
A post-transcriptional process through which a pre-mRNA molecule, containing several introns and exons, can lead to different functional mRNA molecules, and consequently proteins, that originate from a single gene.
- Dominant-negative
-
Describes a mutant molecule that could form a heteromeric complex with the normal molecule, knocking out the activity of the entire complex.
- Long-term depression
-
(LTD). A long-lasting decrease in synaptic strength that can be induced in hippocampal area CA1 by either low-frequency stimulation (NMDA receptor-dependent) or stimulation of group I metabotropic glutamate receptors.
Rights and permissions
About this article
Cite this article
Herz, J., Chen, Y. Reelin, lipoprotein receptors and synaptic plasticity. Nat Rev Neurosci 7, 850–859 (2006). https://doi.org/10.1038/nrn2009
Issue Date:
DOI: https://doi.org/10.1038/nrn2009
This article is cited by
-
Familial hypercholesterolemia in an Iranian family due to a mutation in the APOE gene (first case report)
Journal of Diabetes & Metabolic Disorders (2022)
-
The apolipoprotein receptor LRP3 compromises APP levels
Alzheimer's Research & Therapy (2021)
-
Analysis of the role of Purα in the pathogenesis of Alzheimer's disease based on RNA-seq and ChIP-seq
Scientific Reports (2021)
-
Association Between REELIN Gene Polymorphisms (rs7341475 and rs262355) and Risk of Schizophrenia: an Updated Meta-analysis
Journal of Molecular Neuroscience (2021)
-
Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatment
Hereditas (2020)